GGrantIndex
← Search

PHASE II TRIAL OF MOXIFLOXACIN FOR TB

$453,224R01FY2006FDFDA

Johns Hopkins University, Baltimore MD

Investigators

Linked publications & trials

Abstract

Abstract Not Provided

View original record on NIH RePORTER →